ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 155 filers reported holding ACORDA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.74 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $24,000 | -64.7% | 34,689 | -74.0% | 0.00% | – |
Q3 2020 | $68,000 | -16.0% | 133,194 | +22.3% | 0.00% | – |
Q2 2020 | $81,000 | -28.3% | 108,898 | -10.0% | 0.00% | – |
Q1 2020 | $113,000 | -45.4% | 121,054 | +18.9% | 0.00% | – |
Q4 2019 | $207,000 | -30.3% | 101,825 | -1.7% | 0.00% | – |
Q3 2019 | $297,000 | -52.9% | 103,581 | +25.9% | 0.00% | – |
Q2 2019 | $631,000 | -49.6% | 82,300 | -12.7% | 0.00% | – |
Q1 2019 | $1,253,000 | +3.5% | 94,235 | +21.2% | 0.00% | – |
Q4 2018 | $1,211,000 | -13.7% | 77,760 | +8.9% | 0.00% | – |
Q3 2018 | $1,403,000 | -33.3% | 71,402 | -2.5% | 0.00% | -100.0% |
Q2 2018 | $2,102,000 | -16.1% | 73,243 | -39.0% | 0.00% | 0.0% |
Q1 2018 | $2,506,000 | +22.2% | 120,081 | +25.6% | 0.00% | 0.0% |
Q4 2017 | $2,051,000 | +0.0% | 95,637 | -19.6% | 0.00% | 0.0% |
Q3 2017 | $2,050,000 | +23.0% | 118,957 | +40.6% | 0.00% | 0.0% |
Q2 2017 | $1,667,000 | +57.3% | 84,583 | +67.5% | 0.00% | – |
Q1 2017 | $1,060,000 | +4.3% | 50,499 | -6.5% | 0.00% | – |
Q4 2016 | $1,016,000 | -21.2% | 54,031 | -12.5% | 0.00% | – |
Q3 2016 | $1,290,000 | -24.7% | 61,733 | -8.0% | 0.00% | -100.0% |
Q2 2016 | $1,713,000 | -10.7% | 67,134 | -7.6% | 0.00% | 0.0% |
Q1 2016 | $1,919,000 | -36.3% | 72,618 | +3.2% | 0.00% | 0.0% |
Q4 2015 | $3,011,000 | +60.2% | 70,390 | -0.7% | 0.00% | 0.0% |
Q3 2015 | $1,880,000 | -25.6% | 70,906 | -6.5% | 0.00% | 0.0% |
Q2 2015 | $2,527,000 | -59.3% | 75,797 | -59.4% | 0.00% | 0.0% |
Q1 2015 | $6,210,000 | +57.3% | 186,578 | +93.1% | 0.00% | -50.0% |
Q4 2014 | $3,949,000 | +15.8% | 96,620 | -4.0% | 0.00% | +100.0% |
Q3 2014 | $3,410,000 | +5.3% | 100,672 | +4.8% | 0.00% | 0.0% |
Q2 2014 | $3,239,000 | -22.9% | 96,093 | -13.2% | 0.00% | -50.0% |
Q1 2014 | $4,200,000 | -1.5% | 110,768 | -24.1% | 0.00% | 0.0% |
Q4 2013 | $4,264,000 | -37.2% | 146,034 | -26.4% | 0.00% | -33.3% |
Q3 2013 | $6,787,000 | +25.5% | 198,450 | +21.0% | 0.00% | 0.0% |
Q2 2013 | $5,410,000 | – | 163,998 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |